Primary Site >> Liver Cancer

Gene >> TYMS

Journal: Adv Enzyme Regul. 1991;31:45-67.
Title: Regulation of de novo and salvage pathways in chemotherapy.
Author: Weber, G|Nagai, M|Natsumeda, Y|Ichikawa, S|Nakamura, H|Eble, J N|Jayaram, H N|Zhen, W N|Paulik, E|Hoffman, R
PMID: 1877399
Journal: J Hum Genet. 2003;48(12):609-13.
Title: Association of over-expressed TFDP1 with progression of hepatocellular carcinomas.
Author: Yasui, Kohichiroh|Okamoto, Hiroyuki|Arii, Shigeki|Inazawa, Johji
PMID: 14618416
Journal: Hepatology. 2007 Sep;46(3):749-58.
Title: Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma.
Author: Yuan, Jian-Min|Lu, Shelly C|Van Den Berg, David|Govindarajan, Sugantha|Zhang, Zhen-Quan|Mato, Jose M|Yu, Mimi C
PMID: 17659576
Journal: J Gastroenterol Hepatol. 2008 Mar;23 Suppl 1:S92-7.
Title: Alcohol, cofactors and the genetics of hepatocellular carcinoma.
Author: Yu, Mimi C|Yuan, Jian-Min|Lu, Shelly C
PMID: 18336674
Journal: Hepatology. 2012 Oct;56(4):1240-51.
Title: Subset of Suz12/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein.
Author: Studach, Leo L|Menne, Stephan|Cairo, Stefano|Buendia, Marie Annick|Hullinger, Ronald L|Lefrancois, Lydie|Merle, Philippe|Andrisani, Ourania M
PMID: 22505317
Journal: Clin Res Hepatol Gastroenterol. 2017 Jun;41(3):319-326.
Title: Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.
Author: Wang, X|Sun, X|Du, X|Zhou, F|Yang, F|Xing, J|Dong, G|Guo, X
PMID: 28043790
Journal: Oncol Lett. 2017 Jul;14(1):930-936.
Title: Elevated levels of mRNAs encoding dihydropyrimidine dehydrogenase and thymidylate synthase are associated with improved survival of patients with hepatocellular carcinoma treated with S-1.
Author: Okano, Yusuke|Kuramochi, Hidekazu|Nakajima, Go|Katagiri, Satoshi|Yamamoto, Masakazu
PMID: 28693254